H

Huaxia Eye Hospital Group Co Ltd
SZSE:301267

Watchlist Manager
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
Watchlist
Price: 17.67 CNY 1.96% Market Closed
Market Cap: ¥14.8B

Huaxia Eye Hospital Group Co Ltd
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Huaxia Eye Hospital Group Co Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
H
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
EPS (Diluted)
¥0
CAGR 3-Years
-2%
CAGR 5-Years
6%
CAGR 10-Years
N/A
A
Aier Eye Hospital Group Co Ltd
SZSE:300015
EPS (Diluted)
¥0
CAGR 3-Years
6%
CAGR 5-Years
-4%
CAGR 10-Years
13%
INKON Life Technology Co Ltd
SZSE:300143
EPS (Diluted)
¥0
CAGR 3-Years
N/A
CAGR 5-Years
-16%
CAGR 10-Years
8%
I
Innovative Medical Management Co Ltd
SZSE:002173
EPS (Diluted)
¥0
CAGR 3-Years
10%
CAGR 5-Years
44%
CAGR 10-Years
1%
X
XiAn International Medical Investment Co Ltd
SZSE:000516
EPS (Diluted)
¥0
CAGR 3-Years
32%
CAGR 5-Years
20%
CAGR 10-Years
N/A
S
Sanbo Hospital Management Group Ltd
SZSE:301293
EPS (Diluted)
¥0
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Huaxia Eye Hospital Group Co Ltd
Glance View

Market Cap
14.8B CNY
Industry
Health Care

Huaxia Eye Hospital Group Co Ltd has positioned itself as a key player in China’s healthcare landscape, specializing in comprehensive ophthalmic services. Emerging from the early stirrings of China's reforms in the healthcare sector, Huaxia capitalized on a burgeoning demand for specialized medical care. With roots tracing back to when accessible eye care was a luxury in China, Huaxia recognized the immense potential in providing quality eye treatments. As the country urbanized rapidly, vision ailments became increasingly prevalent, creating a vast market for ocular health services. Huaxia seized this opportunity by establishing a network of state-of-the-art facilities across major cities, providing services ranging from basic eye examinations to complex surgeries. The company's revenue model is built on a multifaceted approach, combining patient volume with specialized treatments. Catering to a diverse demographic, Huaxia offers tiered service options that suit various financial capacities, ensuring a steady stream of income. Beyond individual consultations, the company has fostered partnerships with corporations and insurance providers, further securing a stable client base. Moreover, Huaxia invests significantly in pioneering medical technology and staff training, enhancing its reputation and thereby drawing more patients seeking top-notch care. Through strategic expansion and consistently leveraging advancements in ophthalmology, Huaxia Eye Hospital Group Co Ltd has solidified its place not just as a healthcare provider, but as a critical architect shaping the future of eye care in China.

Intrinsic Value
18.94 CNY
Undervaluation 7%
Intrinsic Value
Price ¥17.67
H

See Also

What is Huaxia Eye Hospital Group Co Ltd's EPS (Diluted)?
EPS (Diluted)
0.5 CNY

Based on the financial report for Dec 31, 2024, Huaxia Eye Hospital Group Co Ltd's EPS (Diluted) amounts to 0.5 CNY.

What is Huaxia Eye Hospital Group Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
6%

Over the last year, the EPS (Diluted) growth was -35%. The average annual EPS (Diluted) growth rates for Huaxia Eye Hospital Group Co Ltd have been -2% over the past three years , 6% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett